Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price gapped down before the market opened on Monday . The stock had previously closed at $9.26, but opened at $8.90. Veradigm shares last traded at $9.45, with a volume of 24,377 shares traded.
Analyst Upgrades and Downgrades
Separately, StockNews.com started coverage on Veradigm in a research note on Friday, November 1st. They issued a “hold” rating on the stock. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $12.00.
Check Out Our Latest Research Report on Veradigm
Veradigm Stock Up 0.2 %
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC acquired a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- How to Use Stock Screeners to Find Stocks
- Astera Labs’ Big Stock Jump: Can the Growth Be Sustained?
- What is MarketRank™? How to Use it
- AMD: The AI Disruptor – Is It Time to Follow Big Tech’s Lead?
- Roth IRA Calculator: Calculate Your Potential Returns
- Analysts Signal Big Upside: Top 3 Stocks to Watch Right Now
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.